Express Scripts Holding Company (ESRX) managed to eke out gains of 0.23% in intraday trade. The share price increased by 0.16 points to $69.04. Till last observation, the net money flow was recorded at a negative $(-3.43) million. The total inflow of $1.34 million in upticks was completely overshadowed by an outflow of $4.77 million in downticks, giving the up/down ratio a value of 0.28. The shares have seen a change of 2.15% in the past week.A block trade occurred in the company shares in which the composite value of the upticks was $0 million and the composite value in downticks was $3.2 million. The resultant up/down ratio for the block exchange was 0. The block trade had a negative money flow of $(-3.2) million.Block trades are executed by Investment Banking firms or Wealth Managers shifting positions or Day traders taking advantage of trading signals.
Express Scripts Holding Company has dropped 0.73% in the last five trading days, however, the shares have posted positive gains of 0.47% in the last 4 weeks. Express Scripts Holding Company is up 2.54% in the last 3-month period. Year-to-Date the stock performance stands at 0.47%. Express Scripts Holding Company (NASDAQ:ESRX) rose 0.33% or 0.23 points on Wednesday and made its way into the gainers of the day. After trading began at $68.65 the stock was seen hitting $69.1519 as a peak level and $68.01 as the lowest level. The stock ended up at $69.11. The daily volume was measured at 3,597,957 shares. The 52-week high of the share price is $80.02 and the 52-week low is $64.46. The company has a market cap of $42,615 million.
Company has reported several Insider transactions to the SEC, on Jan 5, 2017, Everett Neville (Sr. VP, Sup. Chain & Specialty) sold 1,123 shares at 69.41 per share price.On Nov 14, 2016, Steven B Miller (Sr. VP & Chief Med. Officer) sold 21,798 shares at 75.02 per share price.On Nov 14, 2016, Phyllis S. Anderson (Sr. VP & Ch. Marketing Officer) sold 642 shares at 74.74 per share price.
Express Scripts Holding Company Last issued its quarterly earnings results on Oct 25, 2016. The company reported $1.74 EPS for the quarter, beating the analyst consensus estimate by $ 0.01. Analyst had a consensus of $1.73. The company had revenue of $25410.00 million for the quarter, compared to analysts expectations of $25484.56 million. The companys revenue was up .7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.45 EPS.
Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.Company shares were Upgraded by Deutsche Bank on Nov 4, 2016 to Hold, Raises Price Target to $ 70 from a previous price target of $69 .
Express Scripts, Inc. is one of the largest pharmacy benefit management companies in North America. Through facilities in the states and Canada, the company serves thousands of client groups, including managed care organizations, insurance carriers, third-party administrators, employers and union-sponsored benefit plans.